Results 261 to 270 of about 4,586,589 (282)
Some of the next articles are maybe not open access.
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease
Expert Review of NeurotherapeuticsIntroduction: Alzheimer’s disease (AD), the leading cause of dementia, poses a significant burden on patients, caregivers, and healthcare systems worldwide. After two decades of extensive efforts, we are still without significantly effective disease-modifying drugs for AD.
Lozupone, Madia +14 more
openaire +1 more source
Dementia Pharmacotherapy: From Cholinesterase Inhibitors to Anti-Amyloid Therapies
Cholinesterase inhibitors are indicated for mild to moderate dementia and may help treat visual hallucinations in Lewy body or Parkinson's disease dementia. Rivastigmine transdermal patch minimizes GI side effects. Dextromethorphan/quinidine (Nuedexta) may reduce agitation in Alzheimer's disease but requires caution due to QT prolongation and fall risk.openaire +1 more source
Development of a Platinum Complex as an anti‐Amyloid Agent for the Therapy of Alzheimer’s Disease
Angewandte Chemie, 2013Vijaya B, Kenche +14 more
openaire +2 more sources
Progress and Controversies: Radiation Therapy for Prostate Cancer
Ca-A Cancer Journal for Clinicians, 2014Neil E Martin
exaly
Clinical evaluation in anti-amyloid beta antibody therapy
Journal of the Neurological SciencesTaizen Nakase +6 more
openaire +1 more source
Nanooncology: The Future of Cancer Diagnosis and Therapy
Ca-A Cancer Journal for Clinicians, 2013Avnesh S Thakor
exaly